EUCTR2020-002234-32-BE进行中（未招募）1 期
Efficacy and Safety of Edoxaban and or Colchicine for patients with SARS-CoV-2 infection managed in the out of hospital setting (COVID 19) - CorONa Virus edoxabaN ColchicinE (CONVINCE)
Insel Gruppe AG - Bern University Hospital, Department of Cardiology0 个研究点目标入组 60 人开始时间: 2020年10月26日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients = 18 years old with symptoms compatible with active Coronavirus infection and laboratory confirmed SARS-CoV-2 infection (under RT PCR) who are managed at home or in another out-of-hospital setting.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 120
排除标准
- •Hepatic disease associated with coagulopathy and clinically relevant bleeding risk, including Child-Pugh C cirrhosis with portal hypertension.
- •Lesion or condition, if considered to be a significant risk for major bleeding. This may include current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial hemorrhage, known or suspected esophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities.
- •Uncontrolled severe hypertension.
- •Ongoing or planned treatment with parenteral or oral anticoagulants
- •Unilateral or bilateral above knee lower extremity amputation.
- •Inability to take oral medication or otherwise unable or unwilling to undergo/perform study-specified procedures
- •Have received or will receive an experimental drug or used an experimental medical device within 30 days before the planned start of treatment
- •Pregnancy or breast-feeding or any plan to become pregnant during the study. Women (and men, for Colchicine group only) with child-bearing potential not using adequate birth control method (note: as adequate method of birth control oral contraception is recommended. If oral contraception is not feasible, both partners should use adequate barrier birth control).
- •Need for dual anti-platelet therapy consisting of aspirin and an oral P2Y12 inhibitor
- •Inflammatory bowel disease or chronic diarrhea or neuromuscular disease
- •Creatinine clearance (CrCl) <15 ml/min
- •Anticipated use of Hydroxychloroquine
- •Participation in any other clinical trial
- •Inability to understand the requirements of the study and to provide informed consent
研究者
相似试验
进行中（未招募）
1 期
Efficacy and Safety of Edoxaban and or Colchicine for patients with SARS-CoV-2 infection managed in the out of hospital setting (COVID 19)Patients with laboratory confirmed SARS-CoV-2 infection (under RT PCR) who are managed at home or in another out-of-hospital setting.MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-002234-32-ITINSEL GRUPPE AG, BERN UNIVERSITY HOSPITAL, DEPARTMENT OF CARDIOLOGY420
已完成
4 期
Clinical efficacy and safety of edoxaban for treatment of chronic thromboembolic pulmonary hypertensioCTEPH (chronic thromboembolic pulmonary hypertension)JPRN-UMIN000018520Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine60
已完成
不适用
Clinical study on the usefullness of edoxaban tosilate hydrate to portal vein thrombosis complicated with chronic liver diseasePortal vein thrombosisJPRN-UMIN000030108Kanazawa University Hospital20
已完成
不适用
A study on efficacy and safety of Edoxaban on high-risk gastrointestinal endoscopic proceduresAll diseases that require high-risk gastrointestinal endoscopic procedures such as endoscopic polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection or endoscopic mucosal ablationJPRN-UMIN000031523iigata University Graduate School of Medical and Dental Sciences12
招募中
4 期
It is a study that compare two drugs named Ofloxacin and its Combination with Dexamethasone in the patients of long term ear discharge.CTRI/2012/07/002784Government Medical College Bhavnagar120